EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 3)
NCT06160349 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-01-21
Summary
Sepsis is the second leading cause of maternal death in the U.S. For racial and ethnic minoritized birthing people, especially those who are Black, living in poverty, and from underserved communities, labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary observational study is to establish a novel maternal care continuity model to reduce sepsis- related death and disability and increase maternal health equity.
Conditions
- Maternal Sepsis
- Infections
Sponsors & Collaborators
-
Northern Manhattan Perinatal Partnership
collaborator OTHER -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH - lead OTHER
Principal Investigators
-
Dena Goffman, MD · Columbia University
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-20
- Primary Completion
- 2026-08-31
- Completion
- 2026-09-30
Countries
- United States
Study Locations
More Related Trials
-
Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study
NCT02610972 ·Status: COMPLETED
-
mSEP: Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis
NCT05023954 ·Status: UNKNOWN
-
Registry and Survey of Women With Pregnancy Related Cardiomyopathy
NCT00273637 ·Status: UNKNOWN
-
Motherhood and Microbiome
NCT02030106 ·Status: COMPLETED
-
The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study
NCT02357667 ·Status: COMPLETED
-
A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China
NCT05445544 ·Status: RECRUITING
-
Management of Postpartum Preeclampsia
NCT05775744 ·Status: COMPLETED ·Phase: NA
-
Peripartum Anesthetic Management of Patients With Preeclampsia
NCT05237011 ·Status: UNKNOWN
-
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
NCT00550979 ·Status: UNKNOWN
-
Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia
NCT05564988 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
NCT05570630 ·Status: COMPLETED ·Phase: NA
-
A Modernized Approach to Prenatal Care in Low Risk Women
NCT01606774 ·Status: COMPLETED ·Phase: NA
-
Multi-Omics for Maternal Health After Preeclampsia
NCT06340152 ·Status: RECRUITING
-
Characterization and Epigenetics of Post-Partum Preeclampsia
NCT02935556 ·Status: TERMINATED
-
MitoQ to Improve Vascular Funciton in Preeclampsia
NCT07229261 ·Status: RECRUITING ·Phase: NA
-
Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening
NCT03067298 ·Status: COMPLETED
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
NCT02883673 ·Status: COMPLETED ·Phase: NA
-
Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring
NCT01490372 ·Status: COMPLETED
-
Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD
NCT06406998 ·Status: RECRUITING
-
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628 ·Status: RECRUITING
-
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
NCT02147626 ·Status: COMPLETED ·Phase: NA
-
Pre-eclampsia and Metabolomics
NCT00939575 ·Status: UNKNOWN
-
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
HEMAGO Monitoring and Impact on the Occurrence of Complications During Pregnancy in Sickle Cell Patients
NCT06620887 ·Status: COMPLETED
-
Exercise Testing After Preeclampsia
NCT06741436 ·Status: RECRUITING